Integrated DNA Technologies launches new respiratory virus panel
New ready-to-ship xGen NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow
New ready-to-ship xGen NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow
Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from May 14–15
The collaboration aims to create automated and fully compatible nanopore sequencing library preparation for any-length fragments of native DNA/RNA
New collaboration with INRA Micalis-MGP will concentrate on DuPont’s probiotic strains and the understanding of these microbes’ mechanism of action on human health
Learn how to improve your NGS data reliability
Thermo Fisher to introduce Ion AmpliSeq™ On-Demand product line of pre-tested gene targets and several other new Ion Torrent NGS offerings at ESHG 2017
Dr. Megan Allyse from the Mayo Clinic Center for Individualized Medicine explains why gene editing is not yet suitable for medical practice